12 studies found for:    TPI | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Safety Study of TPI-287 to Treat CBS and PSP
Conditions: Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP)
Interventions: Drug: TPI 287 2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
2 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
3 Recruiting Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
4 Recruiting A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TPI-287 2 mg/m2;   Drug: TPI-287 6.3 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo
5 Recruiting Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: TPI 287;   Drug: Temozolomide;   Drug: Irinotecan
6 Recruiting Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma
Intervention: Drug: TPI 287
7 Recruiting Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: TAS-102 with a light tracer dose of [14C]FTD;   Drug: TAS-102 with a light tracer dose of [14C] TPI;   Drug: TAS-102 tablets
8 Recruiting TPI 287 in Breast Cancer Metastatic to the Brain
Condition: Breast Cancer
Interventions: Drug: TPI 287;   Drug: Dexamethasone;   Drug: Benadryl;   Drug: Ranitidine
9 Not yet recruiting Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
Conditions: Brain Metastases;   Generalized Malignancy, Primary;   Brain Lesions
Interventions: Drug: TPI 287;   Procedure: Fractionated Stereotactic Radiotherapy (FSRT)
10 Recruiting Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion
Condition: Major Depressive Disorder
Interventions: Behavioral: psychometric tests;   Device: MRI;   Device: transcranial doppler and TPI;   Behavioral: explicitative interview
11 Recruiting Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain
Condition: Abdominal Pain
Interventions: Drug: Bupivacaine 0.25%;   Drug: Triamcinolone
12 Recruiting Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution
Condition: Cystic Fibrosis
Intervention:

Indicates status has not been verified in more than two years